Hepcidin expression in iron overload diseases is variably modulated by circulating factors
- PMID: 22586470
- PMCID: PMC3346721
- DOI: 10.1371/journal.pone.0036425
Hepcidin expression in iron overload diseases is variably modulated by circulating factors
Abstract
Hepcidin is a regulatory hormone that plays a major role in controlling body iron homeostasis. Circulating factors (holotransferrin, cytokines, erythroid regulators) might variably contribute to hepcidin modulation in different pathological conditions. There are few studies analysing the relationship between hepcidin transcript and related protein expression profiles in humans. Our aims were: a. to measure hepcidin expression at either hepatic, serum and urinary level in three paradigmatic iron overload conditions (hemochromatosis, thalassemia and dysmetabolic iron overload syndrome) and in controls; b. to measure mRNA hepcidin expression in two different hepatic cell lines (HepG2 and Huh-7) exposed to patients and controls sera to assess whether circulating factors could influence hepcidin transcription in different pathological conditions. Our findings suggest that hepcidin assays reflect hepatic hepcidin production, but also indicate that correlation is not ideal, likely due to methodological limits and to several post-trascriptional events. In vitro study showed that THAL sera down-regulated, HFE-HH and C-NAFLD sera up-regulated hepcidin synthesis. HAMP mRNA expression in Huh-7 cells exposed to sera form C-Donors, HFE-HH and THAL reproduced, at lower level, the results observed in HepG2, suggesting the important but not critical role of HFE in hepcidin regulation.
Conflict of interest statement
Similar articles
-
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.J Hepatol. 2008 Jul;49(1):123-33. doi: 10.1016/j.jhep.2008.03.011. Epub 2008 Apr 10. J Hepatol. 2008. PMID: 18462824
-
Hepcidin and Hfe in iron overload in beta-thalassemia.Ann N Y Acad Sci. 2010 Aug;1202:221-5. doi: 10.1111/j.1749-6632.2010.05595.x. Ann N Y Acad Sci. 2010. PMID: 20712796 Free PMC article. Review.
-
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.Lancet. 2003 Feb 22;361(9358):669-73. doi: 10.1016/S0140-6736(03)12602-5. Lancet. 2003. PMID: 12606179
-
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016. Cell Metab. 2008. PMID: 18316026 Free PMC article.
-
[Regulation of body iron homeostasis by hepcidin].Postepy Hig Med Dosw (Online). 2004 Mar 8;58:65-73. Postepy Hig Med Dosw (Online). 2004. PMID: 15069380 Review. Polish.
Cited by
-
The Role of Iron and Iron Overload in Chronic Liver Disease.Med Sci Monit. 2016 Jun 22;22:2144-51. doi: 10.12659/msm.896494. Med Sci Monit. 2016. PMID: 27332079 Free PMC article. Review.
-
Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries.Pathog Glob Health. 2012 Aug;106(4):200-16. doi: 10.1179/2047773212Y.0000000043. Pathog Glob Health. 2012. PMID: 23265420 Free PMC article. Review.
-
Correlation of hepcidin and serum ferritin levels in thalassemia patients at Chiang Mai University Hospital.Biosci Rep. 2021 Feb 26;41(2):BSR20203352. doi: 10.1042/BSR20203352. Biosci Rep. 2021. PMID: 33565577 Free PMC article.
-
Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.Mol Med. 2018 Mar 15;24(1):5. doi: 10.1186/s10020-018-0008-7. Mol Med. 2018. PMID: 30134796 Free PMC article. Review.
-
Risk of Iron Overload in Obesity and Implications in Metabolic Health.Nutrients. 2021 May 2;13(5):1539. doi: 10.3390/nu13051539. Nutrients. 2021. PMID: 34063273 Free PMC article.
References
-
- Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139: 393–408, 408. 2010;e391–392 - PubMed